Hutton Collins Announces Acquisition of Healthcare at Home

Hutton Collins & Company Ltd is pleased to announce that on 2nd August it acquired a significant minority stake in Healthcare at Home from Apax Partners and management shareholders, led by Executive Chairman Charles Walsh and CEO Mike Gordon. Following the transaction, the management team will continue as majority investors in the company.

Founded in 1992 by Charles Walsh, Healthcare at Home is the UK’s largest provider of complex healthcare in the home environment, enhancing the quality of life for its patients through the provision of treatment in the comfort of their own homes.

Healthcare at Home provides prescription management, dispensing and home delivery of complex drug therapies to patients with long term, chronic conditions. The company also provides skilled nursing support, enabling patients with complex or severe conditions to receive treatment outside of traditional institutional settings.

Healthcare at Home currently serves over 40,000 patients and covers every health authority in the UK. The company employs over six hundred people and is based in Burton-upon-Trent, Staffordshire.

Charles Walsh, Executive Chairman of Healthcare at Home, commented:

“Our aim is to shape the future of healthcare. Healthcare at Home has achieved a lot in a short time. With our new partners, Hutton Collins, we can go on to build a truly great British company.”

Graham Hutton, of Hutton Collins, commented:

“We are excited to be entering into partnership with Charles Walsh, Mike Gordon and their team. Healthcare at Home has a clear vision to improve the quality of life for thousands of patients across the UK and Hutton Collins looks forward to supporting the company through its next stage of growth.”

Acquisition debt facilities totalling £175m were underwritten jointly by Nomura International plc and Landsbanki Ireland HF, with Nomura International plc acting as Bookrunner. Hutton Collins was advised by Investec plc, Eversheds LLP, KPMG LLP and Candesic Ltd.